Publicaciones (143) Publicaciones de ANTONIO PORTOLÉS PÉREZ

2024

  1. Adjuvant Arthroscopy Does Not Improve the Functional Outcome of Volar Locking Plate for Distal Radius Fractures: A Randomized Clinical Trial

    Arthroscopy - Journal of Arthroscopic and Related Surgery, Vol. 40, Núm. 2, pp. 305-317

2023

  1. Academia and industry agreement on a feasibility tool for first-time-in-human clinical trial units

    Clinical and Translational Science, Vol. 16, Núm. 12, pp. 2421-2428

2022

  1. Against All Odds? Addiction History Associated with Better Viral Hepatitis Care: A Dutch Nationwide Claims Data Study

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  2. Carisoprodol Single and Multiple Dose PK-PD. Part II: Pharmacodynamics Evaluation Method for Central Muscle Relaxants. Double-Blind Placebo-Controlled Clinical Trial in Healthy Volunteers

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  3. Effect of Obesity and Roux-En-Y Gastric Surgery on Omeprazole Pharmacokinetics

    Obesity Facts, Vol. 15, Núm. 2, pp. 271-280

  4. Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

    The Lancet Infectious Diseases, Vol. 22, Núm. 3, pp. 329-340

  5. Immune Response and Reactogenicity After Immunization With a Suboptimal Two-Dose mRNA Vaccine Followed by a Full Vaccination With a Standard mRNA Vaccine Compared to a Prime-Boost Regimen of a Standard mRNA Vaccine: A Multicenter Cohort Study

    SSRN Electronic Journal

  6. Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study

    eClinicalMedicine, Vol. 51

  7. Immunogenic Dynamics and SARS-CoV-2 Variants Neutralization of the Heterologous ChAdOx1-S/BNT162b2 Vaccination: Secondary Analysis of the CombiVacS Study

    SSRN Electronic Journal

  8. Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study

    eClinicalMedicine, Vol. 50

  9. Immunological safety assessment of a single and repeated intra-articular administration of xenogeneic equine umbilical cord mesenchymal stem cells under field conditions in young healthy dogs: A randomized double-blind placebo-controlled study

    Research in Veterinary Science and Medicine, Vol. 2, pp. 2

  10. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

    The Lancet, Vol. 399, Núm. 10339, pp. 1941-1953

  11. Single and Multiple Dose PK–PD Characterization for Carisoprodol. Part I: Pharmacokinetics, Metabolites, and 2C19 Phenotype Influence. Double-Blind, Placebo-Controlled Clinical Trial in Healthy Volunteers

    Journal of Clinical Medicine, Vol. 11, Núm. 3

2021

  1. European survey on national harmonization in clinical research

    Learning Health Systems, Vol. 5, Núm. 2

  2. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

    The Lancet, Vol. 398, Núm. 10295, pp. 121-130

  3. Repurposed antiviral drugs for COVID-19 — InteriM WHO solidarity trial results

    New England Journal of Medicine, Vol. 384, Núm. 6, pp. 497-511

2020

  1. Chiral bioanalytical methods in bioequivalence studies of intravenous vs. oral formulations of ibuprofen

    Chirality, Vol. 32, Núm. 9, pp. 1169-1177

  2. Docencia de la farmacología clínica en tiempos de pandemia: Limitaciones y oportunidades de innovación docente

    Actas del II Congreso Internacional de Innovación Docente e Investigación en Educación Superior: avanzando en las Áreas de Conocimiento: 11, 12 y 13 de noviembre de 2020

  3. Effect of enantiomerism on the bioequivalence of a new ibuprofen 600-mg tablet formulation obtained by roller compaction

    Chirality, Vol. 32, Núm. 2, pp. 185-190

  4. La isoapariencia farmacéutica: un factor de riesgo de errores de medicación

    Metas de enfermería, Vol. 23, Núm. 7, pp. 7-15